AKT1 and in situ carcinoma: Treatment with 10 μM CIS and 20 μM CIS leads to reduced phosphorylation of AKT at serine residue 473 in SW10 cells (Fig. 4a) and RN33B cells (Fig. 4b) compared to the control.